Thiobenzoic Acid

Thiobenzoic Acid

SCHEMBL160729

OC(=S)c1ccccc1.OC(=S)c1ccccc1

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
MAPT P10636 4/20 0.50
L3MBTL1 Q9Y468 2/20 0.48
MEN1 O00255 2/20 0.48
HPGD P15428 2/20 0.48
KMT2A Q03164 2/20 0.48
HSP90AA1 P07900 1/20 0.48
GAA P10253 1/20 0.48
CES1 P23141 3/20 0.47
CES2 O00748 2/20 0.47
TSHR P16473 2/20 0.47
DAO P14920 1/20 0.47
NAPRT Q6XQN6 1/20 0.47
POLB P06746 2/20 0.43
F2 P00734 2/20 0.43
CYP3A4 P08684 2/20 0.43
BLM P54132 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
F10 P00742 1/20 0.43
F12 P00748 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Thiobenzoic Acid SCHEMBL28199536 1.00 ALDH1A1 (0.50) ALDH1A1MAPTL3MBTL1MEN1HPGD
Thiobenzoic Acid SCHEMBL37018 1.00
Thiobenzoic Acid SCHEMBL15282156 1.00 ALDH1A1 (0.50) ALDH1A1MAPTL3MBTL1MEN1HPGD
Thiobenzoic Acid SCHEMBL284149 0.97 ALDH1A1 (0.48) ALDH1A1MAPTL3MBTL1MEN1HPGD
Thiobenzoic Acid SCHEMBL21806751 0.97 ALDH1A1 (0.48) ALDH1A1MAPTL3MBTL1MEN1HPGD
Thiobenzoic Acid SCHEMBL11305253 0.97 ALDH1A1 (0.48) ALDH1A1MAPTL3MBTL1MEN1HPGD
Thiobenzoic Acid SCHEMBL2165933 0.97 ALDH1A1 (0.48) ALDH1A1MAPTL3MBTL1MEN1HPGD
Thiobenzoic Acid SCHEMBL20741485 0.97 MAPT (0.48) ALDH1A1MAPTL3MBTL1MEN1HPGD
Thiobenzoic Acid SCHEMBL584244 0.97 ALDH1A1 (0.48) ALDH1A1MAPTL3MBTL1MEN1HPGD
Thiobenzoic Acid SCHEMBL11330586 0.97 ALDH1A1 (0.48) ALDH1A1MAPTL3MBTL1MEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1909 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747302-A2 REPAIR AND OPTIMIZATION OF NANOCOMPOSITE MATERIALS Nanocore ApS (DK) 2026-05-27 EP claimed
CN-122080338-A Dispersing agent for high-doping-amount solid carbon steel slag powder cementing material and preparation method thereof 2026-05-26 CN claimed
CN-122008664-A Weather-resistant rubber material for pet trolley and preparation method thereof 湖北逗哈哈科技有限公司 2026-05-12 CN claimed
CN-122010792-A Preparation method of sodium methacryloyl taurate monomer, taurine-containing polymer derived from monomer, preparation method and application thereof 北京科技大学 2026-05-12 CN claimed
EP-4001345-B1 DEGRADABLE HYPERBRANCHED RESIN, PREPARATION METHOD THEREFOR, AND USE THEREOF UNIV SOUTH CHINA TECH (CN) 2026-04-01 EP claimed
WO-2025244983-A1 SELF-HEALING COMPOSITION OF MATTER AND METHODS OF PREPARATION AND USE THEREOF THE PENN STATE RESEARCH FOUNDATION (US) 2025-11-27 WO claimed
CN-120059535-A Thermochromic temperature control coating based on hair structure microcapsules and preparation method thereof 中国铁道科学研究院集团有限公司铁道建筑研究所 2025-05-30 CN claimed
CN-119955539-A Crude oil demulsifier and preparation method thereof 大庆湃瑞环保科技有限公司 2025-05-09 CN claimed
CN-119798562-A Polymer dispersing agent for paint and preparation method thereof 科之杰新材料集团有限公司 2025-04-11 CN claimed
US-12258430-B2 Compositions and methods for labeling and modulation of cells in vitro and in vivo PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2025-03-25 US claimed
EP-1123332-A1 MICROGELS AND PROCESS FOR THEIR PREPARATION E.I. DU PONT DE NEMOURS AND COMPANY (US) 2001-08-16 EP claimed
WO-2000002939-A1 MICROGELS AND PROCESS FOR THEIR PREPARATION E.I. DU PONT DE NEMOURS AND COMPANY (US) 2000-01-20 WO claimed
EP-0609718-B1 Ammonium salts of cyclic diallylpolysulfones CLARIANT GMBH (DE) 1998-12-23 EP claimed
US-5500323-A COPOLYMER OF DIALLYLAMMONIUM COMPOUND AND SULFUR DIOXIDE, ELECTROGRAPHY HOECHST AG (DE) 1996-03-19 US claimed
EP-0133392-B1 PROCESS FOR PREPARING COPOLYMERS IN BEAD FORM, WITH FUNCTIONS, BY SUSPENSION POLYMERISATION IN A NON AQUEOUS MEDIUM SOCIETE NATIONALE ELF AQUITAINE (FR) 1987-04-01 EP claimed
EP-0128833-B1 MONO AND DITHIO ESTERS, THEIR PREPARATION AND USES SOCIETE NATIONALE ELF AQUITAINE (PRODUCTION) (FR) 1987-03-25 EP claimed
US-4566982-A WEAR AND CORROSION RESISTANCE EXXON RESEARCH AND ENGINEERING CO. (US) 1986-01-28 US claimed
EP-0133392-A1 Process for preparing copolymers in bead form, with functions, by suspension polymerisation in a non aqueous medium SOCIETE NATIONALE ELF AQUITAINE (FR) 1985-02-20 EP claimed
US-4456509-A ELECTROLYSIS OF SUBSTITUTED DITHIOBENZOIC ACID WITH METAL; EXXON RESEARCH AND ENGINEERING CO. (US) 1984-06-26 US claimed
US-4259499-A Method for preparing 2-sulfochloride benzoates and the use of same in the preparation of saccharin JAMES RIVER GRAPHICS INC. (US) 1981-03-31 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12258430-B2 Compositions and methods for labeling and modulation of cells in vitro and in vivo CD47, LY6K, CD68 ALDH1A1 1059/4885MAPT 4292/4885L3MBTL1 1807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.